
Keywords: AQP4; aquaporin-4; CNS; central nervous system; CSF; cerebrospinal fluid; EDSS; Expanded Disability Status Scale; ELISA; enzyme-linked immunosorbent assay; FTLD; frontotemporal lobar degeneration; IL; interleukin; mPSL; methylprednisolone; MRI; magnetic r